Clinical PET

[1]  R. Iwata,et al.  Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  M Schulzer,et al.  Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism , 1994, Annals of neurology.

[3]  P. Lewis,et al.  Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  K. Herholz,et al.  Discordant twins with Parkinson's disease: Positron emission tomography and early signs of impaired cognitive circuits , 1994, Annals of neurology.

[5]  L M Hamberg,et al.  The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  N. Gupta,et al.  Diagnostic evaluation of solitary pulmonary nodules (SPNs) using PET-FDG imaging , 1994 .

[7]  V. Lowe,et al.  Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. , 1994, Radiology.

[8]  Gary T. Smith,et al.  Positron emission tomography (PET) for evaluating chest masses , 1994 .

[9]  R. Wahl,et al.  Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. , 1994, Radiology.

[10]  E. Kim,et al.  Differentiation of thoracic tumors from post-treatment changes using PET with F-18 FDG and C-11 methionine , 1994 .

[11]  V. Lowe,et al.  Chest wall FDG accumulation in serial FDG-PET images in patients being treated for bronchogenic carcinoma with radiation , 1994 .

[12]  K. Någren,et al.  Head and neck cancer: effect of food ingestion on uptake of C-11 methionine. , 1994, Radiology.

[13]  R L Wahl,et al.  Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. , 1993, Radiology.

[14]  H. Miyazawa,et al.  PET imaging of non-small-cell lung carcinoma with carbon-11-methionine: relationship between radioactivity uptake and flow-cytometric parameters. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  A. Nordberg.  Effect of long‐term treatment with tacrine (THA) in Alzheimer's disease as visualized by PET , 1993, Acta neurologica Scandinavica. Supplementum.

[16]  D. Slosman,et al.  Satellite PET and lung cancer: a prospective study in surgical patients , 1993, Nuclear medicine communications.

[17]  H. Kimura,et al.  Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levels , 1993, Annals of neurology.

[18]  F Fazio,et al.  Comparability of FDG PET studies in probable Alzheimer's disease. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  R. Coleman,et al.  Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. , 1993, Radiology.

[20]  P Armstrong,et al.  Staging non-small cell lung cancer. , 1993, Clinical radiology.

[21]  K. Kubota,et al.  FDG accumulation in tumor tissue. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  E. Rota Kops,et al.  The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  T Ido,et al.  Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  K. Ishiwata,et al.  Positron Emission Tomography for Treatment Evaluation and Recurrence Detection Compared with CT in Long-Term Follow-up Cases of Lung Cancer , 1992, Clinical nuclear medicine.

[25]  Richard S. J. Frackowiak,et al.  The identification of presymptomatic parkinsonism: Clinical and {18F}dopa positron emission tomography studies in an irish kindred , 1992, Annals of neurology.

[26]  H. Schmoll,et al.  Chemotherapeutic strategies in metastatic colorectal cancer: an overview of current clinical trials. , 1992, Seminars in oncology.

[27]  K. Herholz,et al.  Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type , 1992, Neurobiology of Aging.

[28]  K. Ishiwata,et al.  Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  T. Fukumura,et al.  Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  L G Strauss,et al.  The applications of PET in clinical oncology. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  R Iwata,et al.  Differential diagnosis of lung tumor with positron emission tomography: a prospective study. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  J. Haxby,et al.  Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. , 1990, Archives of neurology.

[33]  S. Kinomura,et al.  Rapid and sensitive response of carbon-11-L-methionine tumor uptake to irradiation. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  David J. Brooks.  Positron Emission Tomographic Studies of the Subcortical Degenerations and Dystonia , 1989, Seminars in neurology.

[35]  F. Buchegger,et al.  Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  J. Hatazawa,et al.  Differential diagnosis of solitary pulmonary nodules with positron emission tomography using [11C]L-methionine. , 1988, Journal of computer assisted tomography.

[37]  K. Herholz,et al.  Effect of Piracetam on Cerebral Glucose Metabolism in Alzheimer's Disease as Measured by Positron Emission Tomography , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  T Jones,et al.  Glucose utilization in vivo by human pulmonary neoplasms , 1987, Cancer.

[39]  R. James,et al.  Quantitative magnetic resonance imaging in rectal carcinoma. , 1987, The British journal of radiology.

[40]  G. di Chiro,et al.  Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study. , 1987, Radiology.

[41]  E. Grabbe,et al.  Local recurrence after sphincter-saving resection for rectal and rectosigmoid carcinoma. Value of various diagnostic methods. , 1985, Radiology.

[42]  D E Kuhl,et al.  Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method , 1984, Annals of neurology.

[43]  D. Aberle,et al.  Whole-Body Positron Emission Tomography and Fluorodeoxyglucose , 2006 .

[44]  A. Alavi,et al.  Standardized uptake values of FDG: body surface area correction is preferable to body weight correction. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  K. Ishiwata,et al.  Dose-responsive effect of radiotherapy on the tumor uptake of L-[methyl-11C]methionine; feasibility for monitoring recurrence of tumor. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[46]  G. van Kaick,et al.  Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score. , 1992, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[47]  S. Rapoport,et al.  Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review. , 1991, Cerebrovascular and brain metabolism reviews.